These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36611001)

  • 81. Clinical assessment incorporating a personal genome.
    Ashley EA; Butte AJ; Wheeler MT; Chen R; Klein TE; Dewey FE; Dudley JT; Ormond KE; Pavlovic A; Morgan AA; Pushkarev D; Neff NF; Hudgins L; Gong L; Hodges LM; Berlin DS; Thorn CF; Sangkuhl K; Hebert JM; Woon M; Sagreiya H; Whaley R; Knowles JW; Chou MF; Thakuria JV; Rosenbaum AM; Zaranek AW; Church GM; Greely HT; Quake SR; Altman RB
    Lancet; 2010 May; 375(9725):1525-35. PubMed ID: 20435227
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacogenomics of warfarin dose requirements in Hispanics.
    Cavallari LH; Momary KM; Patel SR; Shapiro NL; Nutescu E; Viana MA
    Blood Cells Mol Dis; 2011 Feb; 46(2):147-50. PubMed ID: 21185752
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
    Alshabeeb MA; Alyabsi M; Paras B
    Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients.
    Sasano M; Ohno M; Fukuda Y; Nonen S; Hirobe S; Maeda S; Miwa Y; Yokoyama J; Nakayama H; Miyagawa S; Sawa Y; Fujio Y; Maeda M
    Eur J Clin Pharmacol; 2019 Jul; 75(7):901-911. PubMed ID: 30852642
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.
    Yan M; Li D; Zhao G; Li J; Niu F; Li B; Chen P; Jin T
    Gene; 2018 Mar; 648():54-62. PubMed ID: 29337087
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.
    Cacabelos R; Naidoo V; Martínez-Iglesias O; Corzo L; Cacabelos N; Pego R; Carril JC
    Methods Mol Biol; 2022; 2547():275-387. PubMed ID: 36068470
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses.
    Di Fusco D; Ciccacci C; Rufini S; Forte V; Novelli G; Borgiani P
    Thromb Res; 2013 Jul; 132(1):123-6. PubMed ID: 23726967
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics.
    Visscher H; Amstutz U; Sistonen J; Ross CJ; Hayden MR; Carleton BC
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):228-39. PubMed ID: 21386709
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pharmacogenetics of oral anticoagulants: a basis for dose individualization.
    Stehle S; Kirchheiner J; Lazar A; Fuhr U
    Clin Pharmacokinet; 2008; 47(9):565-94. PubMed ID: 18698879
    [TBL] [Abstract][Full Text] [Related]  

  • 91. PharmaKoVariome database for supporting genetic testing.
    Kim J; Choi JP; Kim MS; Bhak J
    Database (Oxford); 2022 Oct; 2022():. PubMed ID: 36255213
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.
    Ye C; Jin H; Zhang R; Sun Y; Wang Z; Sun W; Sun W; Peng Q; Liu R; Huang Y
    J Int Med Res; 2014 Feb; 42(1):67-76. PubMed ID: 24287930
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical applicability of sequence variations in genes related to drug metabolism.
    Stojiljkovic M; Patrinos GP; Pavlovic S
    Curr Drug Metab; 2011 Jun; 12(5):445-54. PubMed ID: 21453274
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effect of VKORC1, CYP2C9, CFP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients.
    Wakamiya T; Hokosaki T; Tsujimoto S; Kadota K; Nakano Y; Watanabe S; Iwamoto M; Yanagimachi M; Ito S
    Mol Diagn Ther; 2016 Aug; 20(4):393-400. PubMed ID: 27262824
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.
    Lu S; Nand RA; Yang JS; Chen G; Gross AS
    Eur J Clin Pharmacol; 2018 Mar; 74(3):285-296. PubMed ID: 29181698
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population.
    Vear SI; Ayers GD; Van Driest SL; Sidonio RF; Stein CM; Ho RH
    Br J Haematol; 2014 Jun; 165(6):832-5. PubMed ID: 24601977
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population.
    Kudzi W; Ahorhorlu SY; Dzudzor B; Olayemi E; Nartey ET; Asmah RH
    BMC Res Notes; 2016 Dec; 9(1):507. PubMed ID: 27938396
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
    Zuo J; Xia D; Jia L; Guo T
    Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione.
    Lacut K; Ayme-Dietrich E; Gourhant L; Poulhazan E; Andro M; Becquemont L; Mottier D; Le Gal G; Verstuyft C
    Br J Clin Pharmacol; 2012 Mar; 73(3):428-36. PubMed ID: 21883387
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes.
    Baranova EV; Verhoef TI; Ragia G; le Cessie S; Asselbergs FW; de Boer A; Manolopoulos VG; Maitland-van der Zee AH;
    J Thromb Haemost; 2017 Mar; 15(3):465-472. PubMed ID: 28063245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.